BML in the News
UW-Madison research team at McPherson Eye Research Institute awarded NIH Grant to Reverse Blindness
September 2016: Gamm’s team (includes scientist Joe Phillips; neuroscience professors Tim Gomez and Xinyu Zhao, and bioengineers Justin Williams and William Murphy) awarded NIH Grant to Reverse Blindness.
Madison, Wisconsin - A UW-Madison research team has been selected to work on one of six projects aimed at restoring vision by regenerating light-sensing photoreceptor cells in the eye. Dr. David Gamm, director of the McPherson Eye Research Institute and associate professor of ophthalmology and visual sciences at the UW School of Medicine and Public Health, and his team will work with a Johns Hopkins team on the project, funded by the National Institutes of Health to reverse blindness.
Together, the projects will receive $12.4 million over three years. They are part of the National Eye Institute (NEI) Audacious Goals Initiative, a targeted effort to restore vision by regenerating neurons and their connections in the eye and visual systems. Read Full Article Here
Steering Organoids Toward Discovery
July 2016: SELF-DRIVING STEM CELLS ARE OPENING A WORLD OF POSSIBILITIES, INCLUDING DRUG TESTING AND TISSUE SOURCING.
Since the 1980s, stem cells’ shape-shifting abilities have wowed scientists. With proper handling, a few growth factors, and some time, stem cells can be cooked up into specific cell types, including neurons, muscle, and skin. However, stem cells know more than they’re given credit for. Over the past decade, researchers have discovered that, left to their own devices, stem cells will generate multiple cell types that assemble into structures resembling an organ. These organoids have been made for many body parts, including the retina, liver, intestine, kidney, and even the brain. Read Full Article Here
3D brain-on-a-chip helps predict drug neurotoxicity
February 2016: NIH-funded engineered brain tissue identifies toxins correctly 9 out of 10 times
To help test the toxicity of new drugs, NIBIB researchers have engineered a 3D brain organoid—a miniature organ structure that attempts to mimic the function of the organ but does not develop fully. In a paper published in PNAS, the teams from the Morgridge Institute for Research and the University of Wisconsin-Madison describe how they developed a chip with neural tissue that possess many traits of brain tissue, including neurons, support cells, vascular structure and immune cells. Read Full Article Here and Here
Stratatech will establish skin tissue inventory in case of natural or man-made emergency
February 2016: Stratatech receives $247 million contract to develop skin product. Stratatech will use the contract money to fund a final phase clinical trial for its flagship StrataGraft product, which is delivered to users frozen, giving it a shelf life of about a year, Allen-Hoffmann said. Stratatech is also developing a large pipeline of enhanced human skin products, including an anti-infective skin, a skin that helps grow new blood vessels underneath it and an anti-tumor skin for patients who have had certain skin cancers.
"Stratatech is an excellent example of how far we've come in cell-based therapies and tissue regeneration, and how close we are to widespread use of these strategies for patients who don't have other options," Bill Murphy said. Read full Article
Baldwin Pushes For New Standards In Regenerative Medicine Industry
January 18, 2016: U.S. Sen. Tammy Baldwin has introduced new legislation to create industry standards for regenerative medicine.
The bill would create a public-private board to set guidelines for regenerative medical products, including those developed from stem cells. Dr. Bill Murphy, co-director of University of Wisconsin-Madison’s Stem Cell and Regenerative Medicine Center, said the standards used currently aren’t specific to the cells and tissues used in the therapies. As these products start to be manufactured outside the research lab, Murphy said companies need guidelines in order for those medicines to be "safe and effective for a broad range of patients."
Murphy said it's important that all stakeholders in regenerative medicine play a part in creating effective guidelines.
"We need to understand, what is the current state of the art in manufacturing these therapies; what do we know about the relationship between the manufacturing process for a product and its safety and efficacy in clinical trials in people; and what are the best practices for manufacturing," Murphy said. Read full Article
New way of developing tissue mimics brain function, has potential to eventually replace animal testing
October 2015: UW scientists develop brain-like structure to improve drug safety testing.
University of Wisconsin scientists have created a structure that mimics brain function and may be used to determine the safety of pharmaceutical drugs and industrial chemicals.
Using a hydrogel, a gel-like substance that readily absorbs water and stem cells, UW and Morgridge Institute for Research scientists have been able to successfully create cellular structures that mimic how brain tissue functions, Michael Schwartz, an assistant scientist in biomedical engineering at UW, said.
The program is called the “Tissue Chip” program, and in addition to UW, there are 10 other universities working on the project. The goal is to create various types of human tissues in order to create better methods of screening pharmaceutical drugs, William Murphy, co-director of the UW Stem Cell and Regenerative Medicine Center, said. Read Full Article Here.
"Brain in a Dish" could replace toxic animal test
September 2015: Scientific American and Francis Collins, NIH director, discuss the potential potential impacts of Michael Schwartz's human brain models on hydrogels. These "Brain in a Dish" models may provide a fast, low cost way to screen drug and chemical neurotoxicity during human brain development. Read Full Articles Here and Here
Stem cell-derived brain mimics predict chemical toxicity
Why drug companies need human tissue- especially liver
July 2015: Bill Murphy talks to the Washington Post about the ethics and importance of human tissue in drug testing and development. Read Full Article
The Canadian military wants to use stem cells to help its soldiers heal
June 2015: Bill Murphy talks to Vice News about the use of stem cells in regenerative technologies capable of healing battlefield injuries Read Full Article
Johnson & Johnson Innovation Center features collaboration with Tissue Regeneration Systems
April 2015: Johnson & Johnson Innovation Center features collaboration with Tissue Regeneration Systems to develop bioresorbable, implantatable devices for skeletal reconstruction and bone regeneration Watch Video Here
α/β-Peptides Could Offer Low-Cost Alternative To Antibody Drugs
April 2015: Samuel H. Gellman, William L. Murphy, Katrina T. Forest, and coworkers have designed a two-helix α/β-peptide with afffinity for VEGF and demonstrated its use by inhibiting the growth of cells lining blood vessels, a process important in limiting the growth of cancerous tissue. Using the same method, the researchers created two modified versions that also selectively bind the large proteins TNF-α and IgG Read Full Article
Researchers aim to broaden understanding of how toxins affect the body
March 2015: Bill Murphy is leading a diverse team of UW-Madison researchers who received $6 million from the EPA Science to Achieve Results (STAR) program. The grant will create the Human Models for Analysis of Pathways (H-MAPs) Center at UW-Madison which will draw on the team's combined expertise to develop "organotypic" culture models as well as robust, practical technological tools that allow researchers to rapidly and reliably screen many toxins simultaneously Read Full Article
WPR: "Tissue Chips" could replace animal testing
February 2015: Wisconsin Public Radio interviews Bill Murphy about how organotypic tissue models developed at Uw-Madison would be used to advance drug screening Listen to the Interview Here
Wisconsin Public Television Wednesday Night at the Lab: 20 years of stem cell milestones at UW-Madison
January 2015: Bill Murphy discusses the history, advances, and new initiatives in stem cell research at UW-Madison Watch Video Here
UW-Madison lecture on Regenerative Medicine: from stem cells to new organs
September 2014: UW-Madison's "Mini Med School" course titled "Regenerative Medicine: from stem cells to new organs" features prominent UW stem cell and regenerative medicine researchers (Tim Kamp, Sean Palecek, Bill Murphy, Jamie Thomson, Sam Gubbels, Amish Raval) who discuss the fundamentals of stem cells and their development for therapeutic applications Watch Lecture Here
Murphy collaboration with Thomson and Page labs receives additional $7 million grant from NIH to develop "organs on a chip" for drug screening
September 2014: A multidisciplinary collaboration between James Thomson, Bill Murphy, and David Page will receive an additional $7 million in NIH funding to continue their work as part of the Tissue Chip for Drug Screening program Read the Press Release
NPR: Big picture science- Replace what ails you
July 2014: NPR interviews Bill Murphy about stem cell use in human therapy Full Interview
Stem cell advances may quell ethics debate
June 2014: USA Today quotes Bill Murphy in an article discussing advances in stem cell research that might quell the public debate concerning the ethics of human embryonic stem cell use Read Full Article
Education, surgery try "speed dating" for research
January 2014: Bill Murphy's collaboration with Craig Kent, chairman of surgery at UW-Madison, is in the spotlight as an example for ambitious surgeons seeking collaborations with engineering faculty to improve health care quality Read Full Article
Materials screening method allows more precise control over stem cells
April 2013: A new non-viral transfection method, developed by Siyoung Choi and Xiaohua Yu, is in the UW-Madison College of Engineering spotlight Read Full Article
Murphy collaboration with Thomson and Page labs receives $2.2 million grant from NIH as part of a $132 billion federal initiative to create "organs on a chip"
July 2012: Bill Murphy's collaboration with James Thomson and David Page receives $2.2 Million NIH grant to develop pluripotent stem cell-based models for predictive neural toxicity and teratogenicity as part of a federal initiative to develop "organs on a chip." Read the UW Press Release, MSNBC Coverage, Wisconsin Journal Sentinel Article, and visit the NIH Central Website for the Program
Proteins as tools for bone repair
February 2012: A modular bone morphogenetic peptide (mBMP), developed by Darilis Suarez-Gonzalez and Jae-Sung Lee featured in Medical New Today, Medical XPress, and the WARF Accelerator Pipeline. Read the full articles Here, Here, Here, and Here
Bill Murphy's lecture on stem cell research and tissue engineering is featured on Wisconsin Public Television
October 2011: Bill Murphy's lecture "Using stem cells to make tissues" for Wednesday Night @ the Lab is featured on Wisconsin Public Television Watch the Broadcast Here
Image provided courtesy of Mark Riechers, University of Wisconsin-Madison College of Engineering
Bill Murphy and Jae-Sung Lee featured for modular bone morphogenetic peptide technology